The company offers unique probes that are smaller than other fluorescent products, which can be used as freely-moving probes or with flexible linkers for specific applications. Lightox is engaged in developing light-activated drug compounds for cancer treatment, allowing for selective elimination of tumor cells without harming healthy cells. They have developed a topically applied drug for early-stage oral cancers that is activated by a specific wavelength of light, enabling specific delivery to the lesion.